Abingdon Health stock price, funding rounds, valuation and financials
Abingdon Health has raised $12.85 m in total funding. Abingdon Health annual revenue was £2.27 m in FY 2018
£2.3 M
Abingdon Health Revenue FY, 2018Abingdon Health Gross profit (FY, 2018)1.7 M
Abingdon Health Gross profit margin (FY, 2018), %74.3%
Abingdon Health Net income (FY, 2018)3.5 M
Abingdon Health EBITDA (FY, 2018)-4.5 M
Abingdon Health EBIT (FY, 2018)-4.7 M
Abingdon Health Cash, 30-Jun-2018476.9 K
Abingdon Health Funding
Summary Metrics
Founding Date | 2008 |
Abingdon Health total Funding | $12.9 m |
Abingdon Health latest funding size | $4.75 m |
Time since last funding | 7 years ago |
Abingdon Health investors | Imperial Innovations |
Abingdon Health's latest funding round in June 2015 was reported to be $4.8 m. In total, Abingdon Health has raised $12.9 m
Abingdon Health Income Statement
Annual
| GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2018 |
|---|---|---|---|---|---|---|---|
Revenue | 78.0k | 782.8k | 1.9m | 1.2m | 1.1m | 1.4m | 2.3m |
Revenue growth, % | (37%) | (5%) | |||||
Cost of goods sold | 358.4k | 696.0k | 328.7k | 326.0k | 333.4k | 583.1k | |
Gross profit | 424.4k | 1.2m | 852.1k | 792.1k | 1.1m | 1.7m | |
Gross profit Margin, % | 54% | 63% | 72% | 71% | 76% | 74% | |
Operating expense total | 20.6k | 1.7m | 2.3m | 3.5m | 3.2m | 3.5m | 6.4m |
EBITDA | (1.3m) | (1.1m) | (2.5m) | (2.3m) | (4.5m) | ||
EBITDA margin, % | (160%) | (57%) | (214%) | (162%) | (196%) | ||
EBIT | 57.4k | (1.3m) | (1.1m) | (2.7m) | (2.5m) | (2.4m) | (4.7m) |
EBIT margin, % | 74% | (164%) | (59%) | (226%) | (220%) | (173%) | (206%) |
Pre tax profit | 33.8k | (1.4m) | (1.2m) | (2.9m) | (3.0m) | (3.6m) | 3.1m |
Income tax expense | 31.8k | 333.7k | 447.6k | 489.8k | 462.2k | ||
Net Income | 33.8k | (1.4m) | (1.2m) | (2.6m) | (2.5m) | (3.2m) | 3.5m |
Abingdon Health Balance Sheet
Annual
| GBP | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 38.2k | 44.5k | 46.0k | 1.2m | 921.0k | 1.2m | 1.7m | 2.0m | 476.9k |
Accounts Receivable | 11.5k | 98.0 | 4.3k | 112.7k | 235.2k | 106.7k | 147.8k | 362.2k | 96.0k |
Inventories | 125.6k | 127.8k | 155.6k | 134.6k | 256.1k | 389.2k | |||
Current Assets | 49.7k | 44.6k | 50.4k | 1.9m | 1.7m | 2.2m | 3.0m | 3.5m | 1.7m |
PP&E | 1.3k | 634.0 | 531.0 | 248.1k | 370.4k | 299.5k | 209.0k | 227.0k | 115.0k |
Goodwill | 694.8k | 4.1m | 4.1m | ||||||
Total Assets | 51.0k | 45.2k | 300.9k | 3.2m | 3.1m | 6.9m | 7.4m | 8.6m | 6.4m |
Accounts Payable | 13.7k | 11.1k | 9.1k | 105.8k | 64.7k | 152.6k | 186.7k | 238.3k | 215.7k |
Current Liabilities | 13.7k | 11.1k | 9.1k | 404.1k | 476.2k | 2.3m | 4.1m | 1.1m | 542.3k |
Non-Current Liabilities | 179.4k | 179.2k | 384.6k | 775.0k | 626.5k | 104.4k | 283.2k | 7.6m | 9.9k |
Total Debt | 402.0 | ||||||||
Total Liabilities | 193.1k | 190.3k | 393.7k | 1.2m | 1.1m | 2.4m | 4.3m | 8.7m | 552.2k |
Common Stock | 483.0 | 813.0 | 1.5k | 3.6k | 4.2k | 6.6k | 7.0k | 7.0k | 11.4k |
Retained Earnings | (2.2m) | (4.6m) | (7.2m) | (10.4m) | (5.8m) | ||||
Total Equity | (142.1k) | (145.0k) | (92.8k) | 2.0m | 2.0m | 4.4m | 3.0m | (115.7k) | 5.9m |
Debt to Equity Ratio | 0 x | ||||||||
Debt to Assets Ratio | 0 x | ||||||||
Financial Leverage | -0.4 x | -0.3 x | -3.2 x | 1.6 x | 1.5 x | 1.6 x | 2.4 x | -74.4 x | 1.1 x |
Abingdon Health Cash Flow
Annual
| GBP | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2018 |
|---|---|---|---|---|---|---|---|
Net Income | 33.8k | (1.4m) | (1.2m) | (2.6m) | (2.5m) | (3.2m) | 3.5m |
Cash From Operating Activities | 36.8k | (894.0k) | (851.3k) | (1.3m) | (1.8m) | (1.7m) | (2.6m) |
Cash From Financing Activities | (16.5k) | 3.4m | 911.3k | 1.6m | 2.7m | 2.8m | 1.4m |
Net Change in Cash | 19.6k | 1.2m | (299.8k) | 240.1k | 565.4k | 307.8k | (1.6m) |
Income Taxes Paid | 31.8k | 333.7k | 440.1k |
Abingdon Health Ratios
| GBP | FY, 2009 |
|---|---|
Financial Leverage | -0.4 x |
